RT @CoffeeBlackMD: GLP1’s showed risk reduction vs insulin in obesity associated cancers in 1.6 million diabetics. Significant risk reduc…
So far, Altmetric has seen
563 X posts from 521 X users, with an upper bound of 5,093,186 followers.
484 followers
3,531 followers
GLP1’s showed risk reduction vs insulin in obesity associated cancers in 1.6 million diabetics. Significant risk reduction in esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancers. https://t.co/2TsQ0cC4mf
211 followers
These are truly the wonder drugs of today https://t.co/zqK3atQhZF
268 followers
Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes https://t.co/3JTIgVnzto